Aspire Biopharma Holdings, Inc. (ASBP) EBIT Margin (2025 - 2026)
Aspire Biopharma Holdings' EBIT Margin came in at -4244.14% for Q2 2026, up 1561.84 percentage points from the prior quarter.
Powered by 
Analysis
Aspire Biopharma Holdings, Inc. (ASBP) EBIT Margin (2025 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aspire Biopharma Holdings reported EBIT Margin of -7494.76%; for FY2025, it was -312016.95%.
- Business Quant data shows ASBP's EBIT Margin at -5805.98% (Q1 2026), -43403.52% (Q4 2025) and -59015.82% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,244.14% |
| Mar 31, 2026 | -5,805.98% |
| Dec 31, 2025 | -43,403.52% |
| Sep 30, 2025 | -59,015.82% |
API Access
Aspire Biopharma Holdings, Inc. EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ASBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ASBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ASBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();